Sign in Sign Up Free

Lynx1 Capital Management LP

Activist investor & 5%+ owner · SC 13D/13G filings

Total Filings

47

Stocks Covered

16

Latest Filing

Feb 17, 2026

Filings

iBio, Inc.

SC 13G/A · Feb 17, 2026

0.0%

0 shares

PRECISION BIOSCIENCES INC

SC 13G/A · Feb 17, 2026

4.1%

994K shares

GH Research PLC

SC 13G/A · Feb 17, 2026

16.8%

10.4M shares

C4 Therapeutics, Inc.

SC 13G/A · Feb 17, 2026

7.3%

7.1M shares

Korro Bio, Inc.

SC 13G · Jan 5, 2026

7.8%

734K shares

Cullinan Therapeutics, Inc.

SC 13G/A · Oct 10, 2025

14.5%

8.5M shares

TScan Therapeutics, Inc.

SC 13G/A · Aug 14, 2025

15.0%

7.9M shares

Cullinan Therapeutics, Inc.

SC 13G · Aug 14, 2025

7.5%

4.4M shares

Allogene Therapeutics, Inc.

SC 13G · Feb 14, 2025

5.2%

10.9M shares

Passage BIO, Inc.

SC 13G/A · Feb 14, 2025

15.0%

9.3M shares

PRECISION BIOSCIENCES INC

SC 13G · Feb 14, 2025

10.0%

766K shares

TScan Therapeutics, Inc.

SC 13G/A · Feb 14, 2025

10.9%

5.4M shares

GH Research PLC

SC 13G/A · Feb 10, 2025

10.2%

6.4M shares

GH Research PLC

SC 13G/A · Feb 10, 2025

9.3%

4.9M shares

Pieris Pharmaceuticals, Inc.

SC 13G/A · Nov 14, 2024

2.8%

37K shares

GH Research PLC

SC 13G/A · Nov 14, 2024

8.1%

4.2M shares

Bionomics Limited

SC 13G/A · Nov 14, 2024

3.2%

98.9M shares

C4 Therapeutics, Inc.

SC 13G/A · Nov 14, 2024

9.9%

6.9M shares

Stoke Therapeutics, Inc.

SC 13G/A · Nov 14, 2024

9.9%

5.2M shares

Passage BIO, Inc.

SC 13G/A · Aug 9, 2024

13.6%

8.4M shares

iBio, Inc.

SC 13G · Apr 1, 2024

10.0%

878K shares

Passage BIO, Inc.

SC 13G · Mar 29, 2024

8.7%

4.8M shares

GH Research PLC

SC 13G · Feb 16, 2024

5.8%

3.0M shares

Alpine Immune Sciences, Inc.

SC 13G/A · Feb 14, 2024

6.6%

3.8M shares

Kinnate Biopharma Inc.

SC 13G/A · Feb 14, 2024

4.2%

2.0M shares

Passage BIO, Inc.

SC 13G/A · Feb 14, 2024

0.7%

379K shares

C4 Therapeutics, Inc.

SC 13G/A · Feb 14, 2024

6.4%

3.1M shares

Stoke Therapeutics, Inc.

SC 13G/A · Feb 14, 2024

6.6%

3.0M shares

Cabaletta Bio, Inc.

SC 13G/A · Feb 14, 2024

5.0%

2.1M shares

Pieris Pharmaceuticals, Inc.

SC 13G/A · Feb 14, 2024

9.9%

9.8M shares

Neurogene Inc. (formerly known as Neoleukin Therapeutics, Inc.)

SC 13G/A · Feb 14, 2024

0.1%

46 shares

Bionomics Limited

SC 13G/A · Feb 14, 2024

7.8%

148.4M shares

C4 Therapeutics, Inc.

SC 13G · Nov 13, 2023

6.3%

3.1M shares

Stoke Therapeutics, Inc.

SC 13G · Nov 6, 2023

6.0%

2.7M shares

Bionomics Limited

SC 13G · Oct 30, 2023

8.2%

154.8M shares

TScan Therapeutics, Inc.

SC 13G · Jun 2, 2023

12.2%

5.2M shares

Cabaletta Bio, Inc.

SC 13G/A · Feb 14, 2023

9.7%

2.8M shares

Passage BIO, Inc.

SC 13G/A · Feb 14, 2023

5.1%

3.4M shares

Pieris Pharmaceuticals, Inc.

SC 13G/A · Feb 14, 2023

7.6%

5.6M shares

Alpine Immune Sciences, Inc.

SC 13G/A · Feb 14, 2023

6.8%

3.1M shares

Kinnate Biopharma Inc.

SC 13G · Jan 23, 2023

5.0%

2.2M shares

Neoleukin Therapeutics, Inc.

SC 13G · Jan 23, 2023

5.0%

3.1M shares

Neoleukin Therapeutics, Inc.

SC 13G · Dec 30, 2022

5.4%

2.3M shares

Cabaletta Bio, Inc.

SC 13G · Oct 31, 2022

8.1%

2.4M shares

Pieris Pharmaceuticals, Inc.

SC 13G · Oct 24, 2022

5.1%

3.8M shares

Passage BIO, Inc.

SC 13G · Sep 29, 2022

5.1%

2.8M shares

Alpine Immune Sciences, Inc.

SC 13G · Apr 22, 2022

5.1%

1.5M shares